{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:22:38Z","timestamp":1793834558485,"version":"4.6.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"New York University Dean's Undergraduate Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous research has uncovered medical and psychological effects of anabolic\u2013androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18\u201347\u00a0years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use.<\/jats:p>","DOI":"10.1038\/s41598-022-13048-w","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:02:44Z","timestamp":1654095764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Anabolic\u2013androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems"],"prefix":"10.1038","volume":"12","author":[{"given":"Bryan S.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Wallisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"13048_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T. & Pallesen, S. The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Ann. Epidemiol. 24, 383\u2013398 (2014).","journal-title":"Ann. Epidemiol."},{"key":"13048_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","volume":"23","author":"HG Pope Jr","year":"2014","unstructured":"Pope, H. G. Jr. et al. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. Am. J. Addict. 23, 371\u2013377 (2014).","journal-title":"Am. J. Addict."},{"key":"13048_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","volume":"104","author":"G Kanayama","year":"2009","unstructured":"Kanayama, G., Brower, K. J., Wood, R. I., Hudson, J. I. & Pope, H. G. Jr. Anabolic-androgenic steroid dependence: An emerging disorder. Addiction 104, 1966\u20131978 (2009).","journal-title":"Addiction"},{"key":"13048_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.02.008","volume":"102","author":"G Kanayama","year":"2009","unstructured":"Kanayama, G., Hudson, J. I. & Pope, H. G. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 102, 130\u2013137 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1517\/13543784.2011.544651","volume":"20","author":"J Woerdeman","year":"2011","unstructured":"Woerdeman, J. & de Ronde, W. Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting. Expert Opin. Investig. Drugs 20, 87\u201397 (2011).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"13048_CR6","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1001\/jama.1988.03410230059028","volume":"260","author":"WE Buckley","year":"1988","unstructured":"Buckley, W. E. et al. Estimated prevalence of anabolic steroid use among male high school seniors. J. Am. Med. Assoc. 260, 3441\u20133445 (1988).","journal-title":"J. Am. Med. Assoc."},{"key":"13048_CR7","unstructured":"National Institute on Drug Abuse. Anabolic Steroids DrugFacts. National Institute on Drug Abuse https:\/\/www.drugabuse.gov\/publications\/drugfacts\/anabolic-steroids (2018)."},{"key":"13048_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1210\/er.2013-1058","volume":"35","author":"HG Pope","year":"2014","unstructured":"Pope, H. G. et al. Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocr. Rev. 35, 341\u2013375 (2014).","journal-title":"Endocr. Rev."},{"key":"13048_CR9","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1017\/S0033291718000508","volume":"48","author":"G Kanayama","year":"2018","unstructured":"Kanayama, G., Pope, H. G. & Hudson, J. I. Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs. Psychol. Med. 48, 2601\u20132608 (2018).","journal-title":"Psychol. Med."},{"key":"13048_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/healthcare9010097","volume":"9","author":"GD Albano","year":"2021","unstructured":"Albano, G. D. et al. Adverse effects of anabolic-androgenic steroids: A literature review. Healthc. Basel 9, 97 (2021).","journal-title":"Healthc. Basel"},{"key":"13048_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJM199304013281304","volume":"328","author":"RH DuRant","year":"1993","unstructured":"DuRant, R. H., Rickert, V. I., Ashworth, C. S., Newman, C. & Slavens, G. Use of multiple drugs among adolescents who use anabolic steroids. N. Engl. J. Med. 328, 922\u2013926 (1993).","journal-title":"N. Engl. J. Med."},{"key":"13048_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00042752-199601000-00004","volume":"6","author":"P Melia","year":"1996","unstructured":"Melia, P., Pipe, A. & Greenberg, L. The use of anabolic-androgenic steroids by Canadian students. Clin. J. Sport Med. 6, 9\u201314 (1996).","journal-title":"Clin. J. Sport Med."},{"key":"13048_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","volume":"34","author":"F Hartgens","year":"2004","unstructured":"Hartgens, F. & Kuipers, H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 34, 513\u2013554 (2004).","journal-title":"Sports Med."},{"key":"13048_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.forsciint.2012.01.004","volume":"219","author":"Y Lood","year":"2012","unstructured":"Lood, Y., Eklund, A., Garle, M. & Ahlner, J. Anabolic androgenic steroids in police cases in Sweden 1999\u20132009. Forensic Sci. Int. 219, 199\u2013204 (2012).","journal-title":"Forensic Sci. Int."},{"key":"13048_CR15","doi-asserted-by":"publisher","unstructured":"Pope Jr, H. G. & Kanayama, G. Anabolic-androgenic steroids. In Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment (Springer, 2012). https:\/\/doi.org\/10.1007\/978-1-4614-3375-0.","DOI":"10.1007\/978-1-4614-3375-0"},{"key":"13048_CR16","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1001\/jama.1993.03500210060032","volume":"269","author":"T-P Su","year":"1993","unstructured":"Su, T.-P. et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. J. Am. Med. Assoc. 269, 2760\u20132764 (1993).","journal-title":"J. Am. Med. Assoc."},{"key":"13048_CR17","doi-asserted-by":"publisher","first-page":"109275","DOI":"10.1016\/j.drugalcdep.2022.109275","volume":"231","author":"M Scarth","year":"2022","unstructured":"Scarth, M. et al. Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway. Drug Alcohol Depend. 231, 109275\u2013109275 (2022).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5694\/j.1326-5377.1996.tb124932.x","volume":"165","author":"B Corrigan","year":"1996","unstructured":"Corrigan, B. Anabolic steroids and the mind. Med. J. Aust. 165, 222\u2013226 (1996).","journal-title":"Med. J. Aust."},{"key":"13048_CR19","first-page":"28","volume":"51","author":"HG Pope Jr","year":"1990","unstructured":"Pope, H. G. Jr. & Katz, D. L. Homicide and near-homicide by abanolic steroid users. J. Clin. Psychiatry 51, 28\u201331 (1990).","journal-title":"J. Clin. Psychiatry"},{"key":"13048_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","volume":"51","author":"HG Pope","year":"1994","unstructured":"Pope, H. G. & Katz, D. L. Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Arch. Gen. Psychiatry 51, 375\u2013382 (1994).","journal-title":"Arch. Gen. Psychiatry"},{"key":"13048_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/add.12715","volume":"110","author":"L Lundholm","year":"2015","unstructured":"Lundholm, L., Frisell, T., Lichtenstein, P. & Langstrom, N. Anabolic androgenic steroids and violent offending: Confounding by polysubstance abuse among 10365 general population men. Addiction 110, 100\u2013108 (2015).","journal-title":"Addiction"},{"key":"13048_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000320286","volume":"16","author":"K Skarberg","year":"2010","unstructured":"Skarberg, K., Nyberg, F. & Engstrom, I. Is there an association between the use of anabolic-androgenic steroids and criminality?. Eur. Addict. Res. 16, 213\u2013219 (2010).","journal-title":"Eur. Addict. Res."},{"key":"13048_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archpsyc.63.11.1274","volume":"63","author":"F Kl\u00f6tz","year":"2006","unstructured":"Kl\u00f6tz, F., Garle, M., Granath, F. & Thiblin, I. Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Arch. Gen. Psychiatry 63, 1274\u20131279 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"13048_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1520\/JFS2002240","volume":"48","author":"P Perry","year":"2003","unstructured":"Perry, P. et al. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J. Forensic Sci. 48, 646\u2013651 (2003).","journal-title":"J. Forensic Sci."},{"key":"13048_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1034\/j.1600-0447.106.s412.27.x","volume":"106","author":"I Thiblin","year":"2002","unstructured":"Thiblin, I. & Parlklo, T. Anabolic androgenic steroids and violence. Acta Psychiatr. Scand. 106, 125\u2013128 (2002).","journal-title":"Acta Psychiatr. Scand."},{"key":"13048_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/026988119200600107","volume":"6","author":"DJ Williamson","year":"1992","unstructured":"Williamson, D. J. & Young, A. H. Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: A brief review of the literature. J. Psychopharmacol. 6, 20\u201326 (1992).","journal-title":"J. Psychopharmacol."},{"key":"13048_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/09585189708412012","volume":"8","author":"I Thiblin","year":"1997","unstructured":"Thiblin, I., Kristiansson, M. & Rajs, J. Anabolic androgenic steroids and behavioural patterns among violent offenders. J. Forensic Psychiatry 8, 299\u2013310 (1997).","journal-title":"J. Forensic Psychiatry"},{"key":"13048_CR28","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00213-019-05239-7","volume":"236","author":"LE Hauger","year":"2019","unstructured":"Hauger, L. E. et al. Anabolic androgenic steroid dependence is associated with impaired emotion recognition. Psychopharmacology 236, 2667\u20132676 (2019).","journal-title":"Psychopharmacology"},{"key":"13048_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archgenpsychiatry.2007.33","volume":"65","author":"OP Almeida","year":"2008","unstructured":"Almeida, O. P., Yeap, B. B., Hankey, G. J., Jamrozik, K. & Flicker, L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch. Gen. Psychiatry 65, 283\u2013289 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"82","key":"13048_CR30","first-page":"294","volume":"1969","author":"A Bj\u00f8rnebekk","year":"2016","unstructured":"Bj\u00f8rnebekk, A. et al. Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters. Biol. Psychiatry 1969(82), 294\u2013302 (2016).","journal-title":"Biol. Psychiatry"},{"key":"13048_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.04.023","volume":"152","author":"MJ Kaufman","year":"2015","unstructured":"Kaufman, M. J. et al. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 152, 47\u201356 (2015).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresbull.2016.05.003","volume":"126","author":"A Gr\u00f6nbladh","year":"2016","unstructured":"Gr\u00f6nbladh, A., Nylander, E. & Hallberg, M. The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. Brain Res. Bull. 126, 127\u2013137 (2016).","journal-title":"Brain Res. Bull."},{"key":"13048_CR33","first-page":"579","volume":"6","author":"A Bj\u00f8rnebekk","year":"2021","unstructured":"Bj\u00f8rnebekk, A. et al. Long-term anabolic-androgenic steroid use is associated with deviant brain aging. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 6, 579\u2013589 (2021).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"13048_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neubiorev.2019.02.014","volume":"100","author":"MJ Kaufman","year":"2019","unstructured":"Kaufman, M. J., Kanayama, G., Hudson, J. I. & Pope, H. G. Supraphysiologic-dose anabolic\u2013androgenic steroid use: A risk factor for dementia?. Neurosci. Biobehav. Rev. 100, 180\u2013207 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"13048_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","volume":"13","author":"D Piacentino","year":"2015","unstructured":"Piacentino, D. et al. Anabolic-androgenic Steroid use and Psychopathology in Athletes. A systematic review. Curr. Neuropharmacol. 13, 101\u2013121 (2015).","journal-title":"Curr. Neuropharmacol."},{"key":"13048_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugalcdep.2012.11.008","volume":"130","author":"G Kanayama","year":"2013","unstructured":"Kanayama, G., Kean, J., Hudson, J. I. & Pope, H. G. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 130, 208\u2013214 (2013).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1037\/neu0000537","volume":"33","author":"A Bj\u00f8rnebekk","year":"2019","unstructured":"Bj\u00f8rnebekk, A. et al. Cognitive performance and structural brain correlates in long-term anabolic-androgenic steroid exposed and nonexposed weightlifters. Neuropsychology 33, 547\u2013559 (2019).","journal-title":"Neuropsychology"},{"key":"13048_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/jnr.22578","volume":"89","author":"F Caraci","year":"2011","unstructured":"Caraci, F. et al. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. J. Neurosci. Res. 89, 592\u2013600 (2011).","journal-title":"J. Neurosci. Res."},{"key":"13048_CR39","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1523\/JNEUROSCI.3108-09.2009","volume":"29","author":"CAA Penatti","year":"2009","unstructured":"Penatti, C. A. A., Porter, D. M. & Henderson, L. P. Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor- and estrogen receptor-mediated mechanisms. J. Neurosci. 29, 12484\u201312496 (2009).","journal-title":"J. Neurosci."},{"key":"13048_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.yhbeh.2011.10.004","volume":"61","author":"S Robinson","year":"2012","unstructured":"Robinson, S., Penatti, C. A. A. & Clark, A. S. The role of the androgen receptor in anabolic androgenic steroid-induced aggressive behavior in C57BL\/6J and Tfm mice. Horm. Behav. 61, 67\u201375 (2012).","journal-title":"Horm. Behav."},{"key":"13048_CR41","doi-asserted-by":"publisher","first-page":"e0177623","DOI":"10.1371\/journal.pone.0177623","volume":"12","author":"A Bueno","year":"2017","unstructured":"Bueno, A., Carvalho, F. B., Gutierres, J. A. M., Lhamas, C. & Andrade, C. M. A comparative study of the effect of the dose and exposure duration of anabolic androgenic steroids on behavior, cholinergic regulation, and oxidative stress in rats. PLoS ONE 12, e0177623\u2013e0177623 (2017).","journal-title":"PLoS ONE"},{"key":"13048_CR42","first-page":"793","volume":"138","author":"LP Henderson","year":"2006","unstructured":"Henderson, L. P., Penatti, C. A. A., Jones, B. L., Yang, P. & Clark, A. S. Anabolic androgenic steroids and forebrain GABAergic transmission. Neuroact. Steroids Old Play. New Game 138, 793\u2013799 (2006).","journal-title":"Neuroact. Steroids Old Play. New Game"},{"key":"13048_CR43","first-page":"177","volume":"58","author":"RH Melloni","year":"2010","unstructured":"Melloni, R. H. & Ricci, L. A. Adolescent exposure to anabolic\/androgenic steroids and the neurobiology of offensive aggression: A hypothalamic neural model based on findings in pubertal Syrian hamsters. Sex Drugs Sex Differ. Horm Eff. Drug Abuse. 58, 177\u2013191 (2010).","journal-title":"Sex Drugs Sex Differ. Horm Eff. Drug Abuse."},{"key":"13048_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11739-009-0260-5","volume":"4","author":"G Quaglio","year":"2009","unstructured":"Quaglio, G. et al. Anabolic steroids: Dependence and complications of chronic use. Intern. Emerg. Med. 4, 289\u2013296 (2009).","journal-title":"Intern. Emerg. Med."},{"key":"13048_CR45","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1007\/s12035-017-0774-1","volume":"55","author":"G Bertozzi","year":"2018","unstructured":"Bertozzi, G. et al. The role of anabolic androgenic steroids in disruption of the physiological function in discrete areas of the central nervous system. Mol. Neurobiol. 55, 5548\u20135556 (2018).","journal-title":"Mol. Neurobiol."},{"key":"13048_CR46","doi-asserted-by":"crossref","unstructured":"Brady, K., Levin, F. R., Galanter, M., Kleber, H. D. & American Psychiatric Association Publishing, issuing body. In The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. (American Psychiatric Association Publishing, 2021).","DOI":"10.1176\/appi.books.9781615373970"},{"key":"13048_CR47","volume-title":"Manual for the Revised Psychopathy Checklist","author":"RD Hare","year":"1991","unstructured":"Hare, R. D. Manual for the Revised Psychopathy Checklist (Multi-Health Systems, 1991)."},{"key":"13048_CR48","volume-title":"Handbook of Psychopathy","author":"CJ Patrick","year":"2005","unstructured":"Patrick, C. J. Handbook of Psychopathy (The Guilford Press, 2005)."},{"key":"13048_CR49","volume-title":"The Psychopath: Emotion and the Brain","author":"J Blair","year":"2005","unstructured":"Blair, J. The Psychopath: Emotion and the Brain (Blackwell, 2005)."},{"key":"13048_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijlp.2009.02.008","volume":"32","author":"J Coid","year":"2009","unstructured":"Coid, J. et al. Psychopathy among prisoners in England and Wales. Int. J. Law Psychiatry 32, 134\u2013141 (2009).","journal-title":"Int. J. Law Psychiatry"},{"key":"13048_CR51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijlp.2012.04.001","volume":"35","author":"M Hildebrand","year":"2012","unstructured":"Hildebrand, M. & de Ruiter, C. Psychopathic traits and change on indicators of dynamic risk factors during inpatient forensic psychiatric treatment. Int. J. Law Psychiatry 35, 276\u2013288 (2012).","journal-title":"Int. J. Law Psychiatry"},{"key":"13048_CR52","doi-asserted-by":"crossref","DOI":"10.5040\/9798216002918","volume-title":"The Psychopathy of Everyday Life: How Antisocial Personality Disorder Affects All of Us","author":"M Kantor","year":"2006","unstructured":"Kantor, M. The Psychopathy of Everyday Life: How Antisocial Personality Disorder Affects All of Us (Praeger, 2006)."},{"key":"13048_CR53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.76.5.893","volume":"76","author":"CS Neumann","year":"2008","unstructured":"Neumann, C. S. & Hare, R. D. Psychopathic traits in a large community sample: Links to violence, alcohol use, and intelligence. J. Consult. Clin. Psychol. 76, 893\u2013899 (2008).","journal-title":"J. Consult. Clin. Psychol."},{"key":"13048_CR54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1037\/0021-843X.99.4.430","volume":"99","author":"SS Smith","year":"1990","unstructured":"Smith, S. S. & Newman, J. P. Alcohol and drug abuse-dependence disorders in psychopathic and nonpsychopathic criminal offenders. J. Abnorm. Psychol. 99, 430\u2013439 (1990).","journal-title":"J. Abnorm. Psychol."},{"key":"13048_CR55","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1037\/0021-843X.111.3.436","volume":"111","author":"M Woodworth","year":"2002","unstructured":"Woodworth, M. & Porter, S. In cold blood: Characteristics of criminal homicides as a function of psychopathy. J. Abnorm. Psychol. 111, 436\u2013445 (2002).","journal-title":"J. Abnorm. Psychol."},{"key":"13048_CR56","unstructured":"Chegeni, R., Sagoe, D., Bergen, S. P. & Maleki, A. The dark triad and big five personality traits in anabolic steroid users (2019)."},{"key":"13048_CR57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/ajad.13157","volume":"30","author":"HG Pope","year":"2021","unstructured":"Pope, H. G., Kanayama, G., Hudson, J. I. & Kaufman, M. J. Review article: Anabolic-androgenic steroids, violence, and crime: Two cases and literature review. Am. J. Addict. 30, 423\u2013432 (2021).","journal-title":"Am. J. Addict."},{"key":"13048_CR58","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/10826084.2018.1512630","volume":"54","author":"M Garcia-Argibay","year":"2019","unstructured":"Garcia-Argibay, M. The relationship between the big five personality traits, impulsivity, and anabolic steroid use. Subst. Use Misuse 54, 236\u2013246 (2019).","journal-title":"Subst. Use Misuse"},{"key":"13048_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000433580","volume":"21","author":"M Hallgren","year":"2015","unstructured":"Hallgren, M. et al. Anti-social behaviors associated with anabolic-androgenic steroid use among male adolescents. Eur. Addict. Res. 21, 321\u2013326 (2015).","journal-title":"Eur. Addict. Res."},{"key":"13048_CR60","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1600-0447.1990.tb05496.x","volume":"81","author":"WR Yates","year":"1990","unstructured":"Yates, W. R., Perry, P. J. & Andersen, K. H. Illicit anabolic steroid use: A controlled personality study. Acta Psychiatr. Scand. 81, 548\u2013550 (1990).","journal-title":"Acta Psychiatr. Scand."},{"key":"13048_CR61","doi-asserted-by":"crossref","unstructured":"Diagnostic and statistical manual of mental disorders\u202f: DSM-5. (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"13048_CR62","doi-asserted-by":"publisher","first-page":"108604","DOI":"10.1016\/j.drugalcdep.2021.108604","volume":"221","author":"LE Hauger","year":"2021","unstructured":"Hauger, L. E., Havnes, I. A., J\u00f8rstad, M. L. & Bj\u00f8rnebekk, A. Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 221, 108604\u2013108604 (2021).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR63","first-page":"265","volume":"56","author":"A Borjesson","year":"2020","unstructured":"Borjesson, A. et al. Male anabolic androgenic steroid users with personality disorders report more aggressive feelings, suicidal thoughts, and criminality. Med. Kaunas Lith. 56, 265 (2020).","journal-title":"Med. Kaunas Lith."},{"key":"13048_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bsl.663","volume":"24","author":"JI Warren","year":"2006","unstructured":"Warren, J. I. & South, S. C. Comparing the constructs of antisocial personality disorder and psychopathy in a sample of incarcerated women. Behav. Sci. Law 24, 1\u201320 (2006).","journal-title":"Behav. Sci. Law"},{"key":"13048_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton, J. H., Stanford, M. S. & Barratt, E. S. Factor structure of the Barratt Impulsiveness Scale. J. Clin. Psychol. 51, 768\u2013774 (1995).","journal-title":"J. Clin. Psychol."},{"key":"13048_CR66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1037\/0022-3514.68.1.151","volume":"68","author":"MR Levenson","year":"1995","unstructured":"Levenson, M. R., Kiehl, K. A. & Fitzpatrick, C. M. Assessing psychopathic attributes in a noninstitutionalized population. J. Pers. Soc. Psychol. 68, 151\u2013158 (1995).","journal-title":"J. Pers. Soc. Psychol."},{"key":"13048_CR67","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer, R. L., Kroenke, K., Williams, J. B. W. & L\u00f6we, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 166, 1092\u20131097 (2006).","journal-title":"Arch. Intern. Med."},{"key":"13048_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff, L. S. The CES-D Scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1, 385\u2013401 (1977).","journal-title":"Appl. Psychol. Meas."},{"key":"13048_CR69","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0146167295215002","volume":"21","author":"CA Anderson","year":"1995","unstructured":"Anderson, C. A., Deuser, W. E. & DeNeve, K. M. Hot temperatures, hostile affect, hostile cognition, and arousal: Tests of a general model of affective aggression. Pers. Soc. Psychol. Bull. 21, 434\u2013448 (1995).","journal-title":"Pers. Soc. Psychol. Bull."},{"key":"13048_CR70","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jesp.2009.04.019","volume":"45","author":"CA Anderson","year":"2009","unstructured":"Anderson, C. A. & Carnagey, N. L. Causal effects of violent sports video games on aggression: Is it competitiveness or violent content?. J. Exp. Soc. Psychol. 45, 731\u2013739 (2009).","journal-title":"J. Exp. Soc. Psychol."},{"key":"13048_CR71","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0191-8869(00)00178-1","volume":"31","author":"CA Brinkley","year":"2001","unstructured":"Brinkley, C. A., Schmitt, W. A., Smith, S. S. & Newman, J. P. Construct validation of a self-report psychopathy scale: Does Levenson\u2019s self-report psychopathy scale measure the same constructs as Hare\u2019s psychopathy checklist-revised?. Personal. Individ. Differ. 31, 1021\u20131038 (2001).","journal-title":"Personal. Individ. Differ."},{"key":"13048_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.paid.2017.02.062","volume":"112","author":"AR Nicholls","year":"2017","unstructured":"Nicholls, A. R., Madigan, D. J., Backhouse, S. H. & Levy, A. R. Personality traits and performance enhancing drugs: The Dark Triad and doping attitudes among competitive athletes. Personal. Individ. Differ. 112, 113\u2013116 (2017).","journal-title":"Personal. Individ. Differ."},{"key":"13048_CR73","doi-asserted-by":"crossref","unstructured":"Volman, I. A. C. et al. Testosterone modulates altered prefrontal control of emotional actions in psychopathic offenders. eNeuro 3, ENEURO.0107\u201315.2016 (2016).","DOI":"10.1523\/ENEURO.0107-15.2016"},{"key":"13048_CR74","first-page":"100","volume":"114","author":"T Dodge","year":"2010","unstructured":"Dodge, T. & Hoagland, M. F. The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Drug Alcohol Depend. 114, 100\u2013109 (2010).","journal-title":"Drug Alcohol Depend."},{"key":"13048_CR75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13011-015-0006-5","volume":"10","author":"D Sagoe","year":"2015","unstructured":"Sagoe, D. et al. Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis. Subst. Abuse Treat. Prev. Policy 10, 12\u201312 (2015).","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"13048_CR76","unstructured":"Ganson, K. T., Jackson, D. B., Testa, A., Murnane, P. M. & Nagata, J. M. Performance-enhancing substance use and sexual risk behaviors among U.S. Men: Results from a prospective cohort study. J. Sex Res. 1\u20137. ahead-of-print."},{"key":"13048_CR77","first-page":"49","volume":"33","author":"E Benson","year":"2002","unstructured":"Benson, E. More male than male. Monit. Psychol. 33, 49 (2002).","journal-title":"Monit. Psychol."},{"key":"13048_CR78","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/10826084.2016.1186696","volume":"51","author":"D Sagoe","year":"2016","unstructured":"Sagoe, D., Mentzoni, R. A., Hanss, D. & Pallesen, S. Aggression is associated with increased anabolic-androgenic steroid use contemplation among adolescents. Subst. Use Misuse 51, 1462\u20131469 (2016).","journal-title":"Subst. Use Misuse"},{"key":"13048_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yhbeh.2009.09.006","volume":"58","author":"G Kanayama","year":"2010","unstructured":"Kanayama, G., Hudson, J. I. & Pope, H. G. Illicit anabolic\u2013androgenic steroid use. Horm. Behav. 58, 111\u2013121 (2010).","journal-title":"Horm. Behav."},{"key":"13048_CR80","doi-asserted-by":"publisher","first-page":"629428","DOI":"10.3389\/fpsyt.2021.629428","volume":"12","author":"R Chegeni","year":"2021","unstructured":"Chegeni, R., Notelaers, G., Pallesen, S. & Sagoe, D. Aggression and psychological distress in male and female anabolic-androgenic steroid users: A multigroup latent class analysis. Front. Psychiatry 12, 629428\u2013629428 (2021).","journal-title":"Front. Psychiatry"},{"issue":"116","key":"13048_CR81","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1037\/0021-843X.116.4.717","volume":"1965","author":"T Hildebrandt","year":"2007","unstructured":"Hildebrandt, T., Langenbucher, J. W., Carr, S. J. & Sanjuan, P. Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: Applications of mixture modeling in 400 regular APED users. J. Abnorm. Psychol. 1965(116), 717\u2013733 (2007).","journal-title":"J. Abnorm. Psychol."},{"key":"13048_CR82","doi-asserted-by":"publisher","first-page":"110780","DOI":"10.1016\/j.paid.2021.110780","volume":"177","author":"M Kowalchyk","year":"2021","unstructured":"Kowalchyk, M., Palmieri, H., Conte, E. & Wallisch, P. Narcissism through the lens of performative self-elevation. Personal. Individ. Differ. 177, 110780 (2021).","journal-title":"Personal. Individ. Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13048-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13048-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13048-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:26:43Z","timestamp":1727335603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13048-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13048-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9133"}}